泰比培南
|
|
|
- CAS号:
- 161715-21-5
- 英文名:
- Tebipenem
- 英文别名:
- LJC11036;LJC-11036;Tebipenem;LJC 11036;Tibipronam;Tebipenem USP/EP/BP;Tebipenem Impurity 5;Tibipenem intermediate 2;inhibit,LJC11036,Bacterial,LJC-11036,Antibiotic,Inhibitor;(4R,5S,6S)-3-[[1-(4,5-Dihydro-2-thiazolyl)-3-azetidinyl]thio]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
- 中文名:
- 泰比培南
- 中文别名:
- 泰比配南;泰比培南;替比培南杂质;泰比培南四水合物;(4R,5S,6S)-3-((1-(4,5-二氢噻唑-2-基)氮杂环丁烷-3-基)硫基)-6-((R)-1-羟乙基)-4-甲基-7-氧代-1-氮杂双环[3.2.0]庚烷-2-烯-2-羧酸
- CBNumber:
- CB52534496
- 分子式:
- C16H21N3O4S2
- 分子量:
- 383.49
- MOL File:
- 161715-21-5.mol
|
|
|
泰比培南化学性质
-
沸点:
-
624.5±65.0 °C(Predicted)
-
|
-
密度:
-
1.75
-
|
-
储存条件:
-
Sealed in dry,Store in freezer, under -20°C
-
|
-
溶解度:
-
insoluble in EtOH; ≥19.15 mg/mL in H2O with gentle warming; ≥24.9 mg/mL in DMSO
-
|
-
形态:
-
solid
-
|
-
酸度系数(pKa):
-
4.29±0.60(Predicted)
-
|
泰比培南性质、用途与生产工艺
Tebipenem 是一种可口服的广谱的碳青霉烯类抗生素，能够抑制革兰氏阳性菌和革兰氏阴性菌，但对绿脓杆菌无作用。
Tebipenem exhibits slow tight-binding inhibition at low micromolar concentrations versus the chromogenic substrate nitrocefin, and apparent K
m
and k
cat
values of 0.8 μM and 0.03 min
-1
, respectively. Tebipenem shows potent activity against
B. pseudomallei
, with MIC
50
and MIC
90
values of both 2 mg/L. Tebipenem shows good activity against
S. pneumoniae
, with the MIC range of ≤0.25 μg/mL in all of the
S. pneumoniae
isolates.
泰比培南
上下游产品信息
上游原料
下游产品
| 更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
|---|
| 2024/04/30 | HY-A0076 | Tebipenem | | 1 mg | 681元 |
| 2024/04/30 | HY-A0076 | 泰比培南
Tebipenem | 161715-21-5 | 5mg | 1500元 |
161715-21-5, 泰比培南 相关搜索:
- API
- 替比培南杂质
- 医药原料药
- (4R,5S,6S)-3-((1-(4,5-二氢噻唑-2-基)氮杂环丁烷-3-基)硫基)-6-((R)-1-羟乙基)-4-甲基-7-氧代-1-氮杂双环[3.2.0]庚烷-2-烯-2-羧酸
- 泰比培南四水合物
- 替比培南杂质
- 泰比配南
- 泰比培南
- 161715-21-5
- Tibipronam
- inhibit,LJC11036,Bacterial,LJC-11036,Antibiotic,Inhibitor
- (4R,5S,6S)-3-[1-(4,5-dihydro-1,3-thiazol-2-yl)azetidin-3-yl]sulfanyl-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
- 1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, 3-[[1-(4,5-dihydro-2-thiazolyl)-3-azetidinyl]thio]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-, (4R,5S,6S)-
- Tibipenem intermediate 2
- (4R,5S,6S)-3-[1-(4,5-dihydro-1,3-thiazol-2-yl)azetidin-3-yl]sulfanyl-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylicaci
- Tebipenem USP/EP/BP
- Tebipenem Impurity 5
- LJC-11036
- LJC11036
- LJC 11036
- (4R,5S,6S)-3-[[1-(4,5-Dihydro-2-thiazolyl)-3-azetidinyl]thio]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
- Tebipenem